Načítá se...
Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease
BACKGROUND: The huntingtin gene (HTT) pathogenic cytosine-adenine-guanine (CAG) repeat expansion responsible for Huntington disease (HD) is phased with single nucleotide polymorphisms (SNPs), providing targets for allele-selective treatments. OBJECTIVE: This prospective observational study defined t...
Uloženo v:
| Vydáno v: | Neurol Genet |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7249892/ https://ncbi.nlm.nih.gov/pubmed/32548276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXG.0000000000000430 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|